When staging preoperative thyroid cancer, ultra-low-dose CT with reduced contrast can produce adequate image quality while also significantly reducing radiation dose compared to standard methods, reported authors of a Dec. 17 study in the American Journal of Roentgenology.

Women with false-positive results from screening mammography had twice the risk of being diagnosed with a screen-detected or interval breast cancer for more than a decade after screening compared to those with negative results, according to research published online Dec. 19 in the British Journal of Cancer.

IRadimed announced Wednesday, Dec. 19, that the company has gained FDA clearance for its 3883 MRI-compatible blood pressure module.

In China, lung cancer is the leading cause of death. Utilizing proper screening can detect and help treat the disease early, but how well does low-dose computed tomography (LDCT) screening work in a large city like Shanghai?

Teenagers hit by thoracic lymphoma can be safely and effectively imaged for primary staging and follow-up care with MRI unenhanced by gadolinium-based contrast agents—or by any contrast at all.

PSMA PET/CT detected more lesions in patients with prostate cancer and resulted in more changes in management than CT alone when utilized prior to radiotherapy, reported authors of a Dec. 14 study in the Journal of Nuclear Medicine.

For patients who undergo weight loss treatments for obesity, a specialized MRI sequence called quantitative chemical shift encoded MRI (CSE-MRI) may provide a safe and noninvasive way to monitor liver fat levels and the success of treatments, according to new research published online Dec. 18 in Radiology.

MRI scans can be used to monitor liver fat levels in obese patients who undergo bariatric surgery, according to new findings published in Radiology.